While the new Shield blood test may motivate more people to get screened for colorectal cancer, it also comes with downsides, ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has ordered the immediate closure of the Gomboru drug ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

Three doctors have expressed concerns to Newsweek about weight loss drugs for children, with research suggesting an initial reluctance to prescribe them.

The United States Food & Drug Administration (FDA) did a routine Good Manufacturing Practice (GMP) inspection at Dr Reddy's ...

Biotech giant Amgen (NASDAQ: AMGN) has had a harsh reminder of that reality in recent years. Some of its most recent ...

SciSparc submits IND application to US FDA for phase IIb trial for Tourette syndrome: Tel Aviv, Israel Friday, September 20, 2024, 17:30 Hrs [IST] SciSparc Ltd., a specialty clini ...

Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") ...

Two Georgia mothers, Amber Thurman and Candi Miller, died in 2022 because of a lack of care most likely tied to the state’s ...